| Holly A Marcum, | |
|
35 Milkshake Ln, Annapolis, MD 21403-1507 | |
| (410) 269-5100 | |
| Not Available |
| Full Name | Holly A Marcum |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 35 Milkshake Ln, Annapolis, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972990380 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 07163 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Holly A Marcum, 35 Milkshake Ln, Annapolis, MD 21403-1507 Ph: () - | Holly A Marcum, 35 Milkshake Ln, Annapolis, MD 21403-1507 Ph: (410) 269-5100 |
News Archive
Over the past year, an entitlement revolution has taken place on Capitol Hill. ... The revolution involves Medicare, the health-care program for the elderly and the single biggest cause of America's looming debt crisis. Reform of Medicare would be achieved by a policy known as "premium support." It would bring consumer choice and spending restraint to the beleaguered program.
Treatment with an inhibitor of 12/15-lipoxygenase, an enzyme elevated in patients with Alzheimer's disease (AD), reverses cognitive decline and neuropathology in an AD mouse model, reports a new study in Biological Psychiatry.
The brains of Alzheimer patients have high accumulations of the material beta-amyloid, which appear in the form of plaques. The precursors of these plaques are believed to be the underlying cause of the nerve cell loss that leads to the disruptions in memory that characterize Alzheimer's disease. The main aim of many Alzheimer therapies is therefore to inhibit the formation of beta-amyloid. Since beta-amyloid is cleaved from the so-called amyloid precursor protein (APP), scientists have focused on stopping the two enzymes that attack the precursor protein. These act like molecular scissors and cut out the beta-amyloid fragment. Blocking these scissors precludes the formation of beta-amyloid.
Ember Therapeutics, Inc., a Boston-based biotechnology company dedicated to the discovery and development of novel obesity and diabetic related therapies, and Mariel Therapeutics, a privately held, New York-based biotechnology company developing targeted therapies for osteoarthritis and kidney fibrosis using Bone Morphogenetic Protein (BMP)-7, jointly announce today that they have entered into a definitive agreement to merge the two companies.
› Verified 3 days ago
Mrs. Lindsay Arna Oconnor, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 7101 Bay Front Dr, Annapolis, MD 21403 Phone: 443-837-0026 | |
Ann Ruppel, OTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 2003 Medical Pkwy, Annapolis, MD 21401 Phone: 410-573-2530 | |
Mrs. Cimmon Elizabeth Burris, OT/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000 | |
Physiotherapy Associates, Inc. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 129 Lubrano Dr Ste 301, Annapolis, MD 21401 Phone: 410-224-2626 | |
Kristin Abboud, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2000 Medical Pkwy, Ste 101, Annapolis, MD 21401 Phone: 410-295-8900 Fax: 410-280-4701 | |
Robin Joanne Mullins, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000 | |
Emiko Tanabe, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1410 Forest Dr Ste 29, Annapolis, MD 21403 Phone: 410-280-8774 |